First-line osimertinib in patients with EGFR-mutated advanced non-small cell lung cancer
Ann Transl Med
.
2018 Feb;6(3):62.
doi: 10.21037/atm.2017.12.30.
Authors
Byeong-Ho Jeong
1
,
Sang-Won Um
1
Affiliation
1
Division of Pulmonary and Critical Care Medicine, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.
PMID:
29610752
PMCID:
PMC5879504
DOI:
10.21037/atm.2017.12.30
No abstract available
Publication types
Editorial
Comment